JP2009539987A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539987A5
JP2009539987A5 JP2009515450A JP2009515450A JP2009539987A5 JP 2009539987 A5 JP2009539987 A5 JP 2009539987A5 JP 2009515450 A JP2009515450 A JP 2009515450A JP 2009515450 A JP2009515450 A JP 2009515450A JP 2009539987 A5 JP2009539987 A5 JP 2009539987A5
Authority
JP
Japan
Prior art keywords
seq
tetrapeptide
formula
composition
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009515450A
Other languages
English (en)
Japanese (ja)
Other versions
JP5535620B2 (ja
JP2009539987A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/013748 external-priority patent/WO2007146269A2/en
Publication of JP2009539987A publication Critical patent/JP2009539987A/ja
Publication of JP2009539987A5 publication Critical patent/JP2009539987A5/ja
Application granted granted Critical
Publication of JP5535620B2 publication Critical patent/JP5535620B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009515450A 2006-06-13 2007-06-12 細胞外マトリックスタンパク質の合成を誘導するペプチドフラグメント Active JP5535620B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81328406P 2006-06-13 2006-06-13
US60/813,284 2006-06-13
PCT/US2007/013748 WO2007146269A2 (en) 2006-06-13 2007-06-12 Peptide fragments for inducing synthesis of extracellular matrix proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014025001A Division JP5844834B2 (ja) 2006-06-13 2014-02-13 細胞外マトリックスタンパク質の合成を誘導するペプチドフラグメント

Publications (3)

Publication Number Publication Date
JP2009539987A JP2009539987A (ja) 2009-11-19
JP2009539987A5 true JP2009539987A5 (https=) 2010-07-22
JP5535620B2 JP5535620B2 (ja) 2014-07-02

Family

ID=38664422

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009515450A Active JP5535620B2 (ja) 2006-06-13 2007-06-12 細胞外マトリックスタンパク質の合成を誘導するペプチドフラグメント
JP2014025001A Active JP5844834B2 (ja) 2006-06-13 2014-02-13 細胞外マトリックスタンパク質の合成を誘導するペプチドフラグメント

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014025001A Active JP5844834B2 (ja) 2006-06-13 2014-02-13 細胞外マトリックスタンパク質の合成を誘導するペプチドフラグメント

Country Status (19)

Country Link
US (5) US8110658B2 (https=)
EP (5) EP2940042A3 (https=)
JP (2) JP5535620B2 (https=)
CN (2) CN101472944B (https=)
AT (1) ATE533785T1 (https=)
AU (1) AU2007258387B2 (https=)
BR (2) BRPI0713153B8 (https=)
CA (4) CA2947353A1 (https=)
CY (1) CY1112241T1 (https=)
DK (3) DK2027152T3 (https=)
ES (4) ES2557402T3 (https=)
HK (1) HK1210791A1 (https=)
HU (2) HUE027273T2 (https=)
MX (2) MX2008016011A (https=)
PL (4) PL3002294T3 (https=)
PT (2) PT2402369E (https=)
RU (2) RU2441877C2 (https=)
SI (2) SI2027152T1 (https=)
WO (1) WO2007146269A2 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2557402T3 (es) * 2006-06-13 2016-01-25 Helix Biomedix Inc. Fragmentos peptídicos para inducir la síntesis de proteínas de la matriz extracelular
ES2421262T3 (es) * 2007-11-30 2013-08-30 Evonik Goldschmidt Gmbh Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
WO2009111471A2 (en) * 2008-03-03 2009-09-11 Henry Ford Health System Collagen-derived peptide as biomarker, therapeutic agent and target
RU2482127C2 (ru) * 2008-12-30 2013-05-20 Гкл-Биотек Аг Комбинация пептидов
WO2011044443A2 (en) 2009-10-09 2011-04-14 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Matricryptic ecm peptides for tissue reconstruction
WO2014004719A2 (en) 2012-06-26 2014-01-03 Worcester Polytechnic Institute Matrix scaffold with antimicrobial activity
CN105120884B (zh) * 2013-02-14 2017-08-29 赫里克斯生物医疗公司 用于促进伤口愈合的短生物活性肽
WO2014140890A2 (en) * 2013-03-13 2014-09-18 Neocutis Sa Peptides for skin rejuvenation and methods of using the same
US10392611B2 (en) 2013-05-30 2019-08-27 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
US10364451B2 (en) 2013-05-30 2019-07-30 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
CN105324122B (zh) * 2013-06-14 2019-08-27 赫里克斯生物医疗公司 可用于治疗多种皮肤病的衍生自人类c-x-c趋化因子的四肽
US10385115B2 (en) 2015-03-26 2019-08-20 Duke University Fibronectin type III domain-based fusion proteins
EA037478B1 (ru) 2015-08-04 2021-04-01 Дьюк Юниверсити Генетически кодируемые внутренне неупорядоченные полимеры-"невидимки" для доставки и способы их применения
KR101916522B1 (ko) 2015-09-25 2018-11-08 경상대학교산학협력단 굴 가수분해물의 제조방법 및 이로부터 분리된 펩타이드
US11752213B2 (en) 2015-12-21 2023-09-12 Duke University Surfaces having reduced non-specific binding and antigenicity
WO2017210476A1 (en) 2016-06-01 2017-12-07 Duke University Nonfouling biosensors
WO2018053201A1 (en) * 2016-09-14 2018-03-22 Duke University Triblock polypeptide-based nanoparticles for the delivery of hydrophilic drugs
JP2020500150A (ja) 2016-09-23 2020-01-09 デューク ユニバーシティ 下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド
WO2018132732A1 (en) 2017-01-12 2018-07-19 Duke University Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
JP6489487B2 (ja) * 2017-01-20 2019-03-27 富比積生物科技股▲分▼有限公司 テトラペプチド−3 gekgまたはペンタペプチド−3 gekgfにより変形性関節症を治療するための新規用途
JP6489486B2 (ja) * 2017-01-20 2019-03-27 富比積生物科技股▲分▼有限公司 ペンタペプチド/ヘキサペプチドにより変形性関節症を治療するための新規用途
WO2018213320A1 (en) 2017-05-15 2018-11-22 Duke University Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
WO2019006374A1 (en) 2017-06-30 2019-01-03 Duke University ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
WO2019147954A1 (en) 2018-01-26 2019-08-01 Duke University Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
EP3788343B1 (en) 2018-04-30 2024-03-27 Duke University Stimuli-responsive peg-like polymer-based drug delivery platform
US11649275B2 (en) 2018-08-02 2023-05-16 Duke University Dual agonist fusion proteins
US12594347B2 (en) 2018-09-07 2026-04-07 Duke University Nanoparticulate drug delivery systems
US11512314B2 (en) 2019-07-12 2022-11-29 Duke University Amphiphilic polynucleotides
EP4000597A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
EP4000598A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
EP4000595A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
EP4000596A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
EP4140473A1 (en) * 2021-08-27 2023-03-01 The Boots Company plc Cosmetic compositions
CN115990240A (zh) * 2021-10-20 2023-04-21 富比积生物科技股份有限公司 寡肽在治疗牙龈发炎、牙龈萎缩及修复口腔黏膜中的用途
CN114437238B (zh) * 2022-01-26 2024-03-26 浙江工业大学 胶原蛋白肽-牛乳铁蛋白肽融合蛋白、基因及其表达方法
CN115894615B (zh) * 2022-10-19 2026-04-07 上海高科生物工程有限公司 一种抗皮肤衰老的五肽衍生肽段ys及其应用
CN116375847B (zh) * 2022-10-26 2025-06-13 江苏创健医疗科技股份有限公司 酵母重组xvii型人源化胶原蛋白及其制备方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU466760B2 (en) * 1972-03-14 1975-11-06 Takeda Chemical Industries Ltd. Process for producing peptide
US5064430A (en) * 1985-10-31 1991-11-12 Uab Research Foundation Polynonapeptide bioelastomers having an increased elastic modulus
JP2573006B2 (ja) * 1987-12-17 1997-01-16 富士薬品工業株式会社 新規なヒドロキサム酸誘導体
JP2820750B2 (ja) 1988-04-21 1998-11-05 ユーエービー リサーチ ファウンデイション 創傷治療部位における癒着の発生からの保護に適するバイオエラストマー材料
CA2032527C (en) 1989-04-10 2002-07-02 Jesse M. Jaynes Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth
US5679770A (en) * 1991-11-08 1997-10-21 Mochida Pharmaceutical Co., Ltd. Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
US6132976A (en) * 1992-12-04 2000-10-17 Shriners Hospitals For Children Immunoassays for the measurement of collagen denaturation and cleavage in cartilage
IL104954A (en) * 1993-03-04 2006-08-01 Yissum Res Dev Co Use of osteogenic oligopeptides in the preparation of pharmaceutical compositions for the treatment of bone diseases and some such novel oligopeptides, pharmaceutical compositions containing them and their preparation
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
JPH07227281A (ja) * 1994-02-15 1995-08-29 Agency Of Ind Science & Technol ペプチダーゼ及びその製造法
US5763576A (en) * 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
US6159940A (en) * 1996-02-28 2000-12-12 Immunotech Developments Inc. Method for modulating hemopoiesis
DE19651099A1 (de) * 1996-12-09 1998-06-10 Consortium Elektrochem Ind Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
EP1074620A1 (en) * 1999-08-06 2001-02-07 HyGene AG Monomeric protein of the TGF-beta family
EP0858808B1 (en) * 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptides for use in wound treatment
US6639050B1 (en) * 1997-07-21 2003-10-28 Ohio University Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
GB2341182A (en) * 1998-09-01 2000-03-08 Yamanouchi Uk Ltd Protein comprising amino acid sequences having SH3 domain binding activity and nuclear localisation activity
US6747135B1 (en) * 1998-10-16 2004-06-08 The Board Of Trustees For The Leland Stanford Junior University Fluorescent dye binding peptides
US6492326B1 (en) * 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
CA2276542C (en) 1999-06-28 2013-07-30 Vladislav I. Deigin Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
CN1280983A (zh) * 1999-07-16 2001-01-24 王革 白细胞介素-11的衍生物及其制备方法
US6627785B1 (en) * 2000-02-29 2003-09-30 Virginia Commwealth University Wound dressings with protease-lowering activity
WO2001079561A2 (en) * 2000-04-17 2001-10-25 Liggett Stephen B Alpha-2 adrenergic receptor polymorphisms
US20030166510A1 (en) * 2000-10-11 2003-09-04 Pickart Loren R. Methods and compositions for increasing skin remodeling
GB0029777D0 (en) * 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
CA2441562C (en) 2001-03-28 2013-05-14 Helix Biomedix, Inc. Short bioactive peptides and methods for their use
US7186693B2 (en) * 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7041506B2 (en) * 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
EP1534308A4 (en) * 2001-11-28 2007-03-14 Becton Dickinson Co PEPTIDES WITH INHIBITORY ACTION OF GROWTH
US20040009911A1 (en) * 2002-01-31 2004-01-15 Irm, Llc Hepsin substrates and prodrugs
US7491691B2 (en) * 2002-05-03 2009-02-17 Sindrey Dennis R Connective tissue stimulating peptides
JP4510630B2 (ja) * 2002-09-09 2010-07-28 ユニバーシティ オブ シンシナティ 個体における心血管疾患を評価する方法
US7541440B2 (en) * 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
TWI256893B (en) * 2003-03-25 2006-06-21 Fancl Corp Composition for promoting production of type I collagen and/or elastin
DE10339180A1 (de) * 2003-08-21 2005-03-24 Deutsche Gelatine-Fabriken Stoess Ag Kollagenhydrolysat
US7638318B2 (en) 2003-09-26 2009-12-29 Norvartis Ag Seneca Valley virus based compositions and methods for treating disease
EP1686957B1 (en) 2003-11-17 2012-03-07 Sederma Compositions containing mixtures of tetrapeptides and tripeptides
JP2005245285A (ja) * 2004-03-03 2005-09-15 National Institute Of Advanced Industrial & Technology コラーゲン分解物の製造方法
DE102005000868A1 (de) * 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren
DE102004050563A1 (de) * 2004-10-15 2006-04-20 Henkel Kgaa Kosmetische und der dermatologische Zusammensetzungen mit Wirkstoffen für einen verbesserten Hautkomfort
DE102004055541A1 (de) * 2004-11-17 2006-05-18 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut
DE202004012807U1 (de) * 2004-08-13 2004-10-21 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden
WO2006028993A2 (en) * 2004-09-02 2006-03-16 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
CA2583113C (en) * 2004-10-05 2015-11-10 Diversa Corporation Compositions comprising an antigen and a promiscuous t-cell epitope
US8044028B2 (en) * 2004-10-18 2011-10-25 Cognis France S.A.S. Oligopeptides and their use in cosmetics
WO2006048339A2 (en) * 2004-11-04 2006-05-11 L'oréal Cosmetic composition comrising an active agent and a urea compound
US20070224150A1 (en) * 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
FR2884418B1 (fr) * 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー.フェー. 腫瘍の治療
DE102005063062A1 (de) * 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
US7807625B2 (en) * 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition
ES2557402T3 (es) * 2006-06-13 2016-01-25 Helix Biomedix Inc. Fragmentos peptídicos para inducir la síntesis de proteínas de la matriz extracelular

Similar Documents

Publication Publication Date Title
JP2009539987A5 (https=)
RU2009100884A (ru) Пептидные фрагменты для индукции синтеза белков внеклеточного матрикса
CN101395179B (zh) 具有胰岛素样生长因子-i活性的肽及其用途
CN101522708B (zh) 具有表皮生长因子活性的肽及其用途
CN102348716B (zh) 头蛋白-来源的肽及其用途
JP2011502121A5 (https=)
CN101296939B (zh) 用于促进毛发生长和改善皱纹的肽以及包含该肽的化妆品组合物
CN113271920B (zh) 用于化妆品的肽和组合物
WO2007087738A1 (de) Biologisch aktive tripeptide, deren kupferkomplexe und salze
WO2010008219A3 (ko) 지방조직 유래 다분화능 줄기세포의 배양물 및 그 추출 단백질을 함유한 화장료용 조성물
KR101092915B1 (ko) 성장인자―유래 펩타이드 및 이의 용도
CN114869796A (zh) 含活性多肽的美白亮肤修复组合物及其用途
KR20140074527A (ko) 피부노화 방지용 테트라펩타이드 및 이를 함유하는 화장료 조성물
WO2018021839A1 (ko) 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물
US7750115B2 (en) Epithelial cell growth promoter
CN116098828A (zh) 四肽衍生物在制备用于皮肤修复紧致的组合物中的新用途
KR101667383B1 (ko) 비오틴이 결합된 hexapeptide-2 유도체 및 이의 용도
KR101870898B1 (ko) 갈릭산이 결합된 펩타이드 유도체 및 그를 포함하는 항노화 피부 외용제 조성물
CN117624289A (zh) 一种抗皱三肽及其衍生物和应用
RU2009129950A (ru) Короткие биологически активные пептиды для клеточной и иммунологической модуляции
BRPI0621609A2 (pt) composição, usos de pelo menos um composto, e de uma composição, e, compostos
CN110520162A (zh) 水杨酸和肽的结合体
KR101224809B1 (ko) 레티노산 유도체, 이의 제조 방법 및 이를 포함하는 화장품 조성물
HK40048117A (en) Peptides and compositions for use in cosmetics
TH97975A (th) ชิ้นส่วนเปปไทด์สำหรับการชักนำการสังเคราะห์แมทริกซ์โปรตีนภายนอกเซลล์